title: Deterioration of glycaemic control associated with anti-insulin antibodies likely induced by health supplements.
authors.forename: Y
authors.initials: Y
authors.lastname: Hirota
authors.forename: W
authors.initials: W
authors.lastname: Ogawa
authors.forename: A
authors.initials: A
authors.lastname: Murawaki
authors.forename: T
authors.initials: T
authors.lastname: Nishiumi
authors.forename: H
authors.initials: H
authors.lastname: Komada
authors.forename: K
authors.initials: K
authors.lastname: Miyake
authors.forename: K
authors.initials: K
authors.lastname: Sakaguchi
authors.forename: M
authors.initials: M
authors.lastname: Kasuga
mesh_terms: D000368:Aged; D001786:Blood Glucose / Q000187:drug effects*; D000529:Complementary Therapies / Q000009:adverse effects*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D007330:Insulin Antibodies / Q000187:drug effects*
chemical_list: D001786:Blood Glucose; D007328:Insulin; D007330:Insulin Antibodies